We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$301B
AUM Growth
+$28B
Cap. Flow
+$8.83B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.6%
Holding
3,648
New
163
Increased
2,481
Reduced
676
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Financials 13.07%
3 Healthcare 12.05%
4 Consumer Discretionary 10.98%
5 Industrials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATLO icon
3251
AMES National
ATLO
$271M
$275K ﹤0.01%
11,198
-18,809
-63% -$475K
VEL icon
3252
Velocity Financial
VEL
$696M
$274K ﹤0.01%
+21,927
New +$233K
CRCT icon
3253
Cricut
CRCT
$1.01B
$267K ﹤0.01%
+6,259
New +$176K
TERN
3254
DELISTED
Terns Pharmaceuticals
TERN
$262K ﹤0.01%
21,359
ALPN
3255
DELISTED
Alpine Immune Sciences Inc
ALPN
$259K ﹤0.01%
+28,760
New +$313K
PAMT
3256
PAMT Corp
PAMT
$360M
$257K ﹤0.01%
19,476
+3,344
+21% +$48.5K
IBEX icon
3257
IBEX
IBEX
$489M
$250K ﹤0.01%
12,767
HQI icon
3258
HireQuest
HQI
$190M
$249K ﹤0.01%
+13,405
New +$258K
APRE icon
3259
Aprea Therapeutics
APRE
$7.69M
$246K ﹤0.01%
2,518
-910
-27% -$84.1K
STSA
3260
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$243K ﹤0.01%
34,327
-21,558
-39% -$116K
LHDX
3261
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$242K ﹤0.01%
36,397
-31,227
-46% -$197K
GBLI icon
3262
Global Indemnity Group
GBLI
$402M
$236K ﹤0.01%
8,941
-1,611
-15% -$47K
PARAA
3263
DELISTED
Paramount Global Class A
PARAA
$236K ﹤0.01%
4,855
-794
-14% -$36.2K
VINC
3264
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$224K ﹤0.01%
+860
New +$262K
CLPR
3265
Clipper Realty
CLPR
$46.4M
$223K ﹤0.01%
30,300
-7,074
-19% -$57.4K
VCTR icon
3266
Victory Capital Holdings
VCTR
$6.09B
$222K ﹤0.01%
+6,857
New +$200K
PLM
3267
DELISTED
PolyMet Mining Corp.
PLM
$221K ﹤0.01%
+61,184
New +$192K
BAB icon
3268
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$219K ﹤0.01%
6,610
-368
-5% -$12K
VERX icon
3269
Vertex
VERX
$2.16B
$202K ﹤0.01%
9,192
ASTS icon
3270
AST SpaceMobile
ASTS
$15.8B
$200K ﹤0.01%
+15,424
New +$139K
SRTA
3271
Strata Critical Medical Inc
SRTA
$421M
$190K ﹤0.01%
+18,079
New +$178K
RVLP
3272
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$187K ﹤0.01%
61,991
-23,870
-28% -$73.1K
KIN
3273
DELISTED
Kindred Biosciences, Inc.
KIN
$173K ﹤0.01%
18,803
-77,623
-81% -$452K
NH
3274
DELISTED
NantHealth, Inc
NH
$171K ﹤0.01%
4,899
PRTH icon
3275
Priority Technology Holdings
PRTH
$554M
$168K ﹤0.01%
21,956
+4,102
+23% +$29.5K

Similar funds

Charles Schwab's Q2 2021 Portfolio in Review

As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
  • Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
  • Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
  • Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
  • Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
  • Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.